Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Pharmacoeconomics
|
August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer
Steven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Journal of the Neurological Sciences
|
July 6, 2015
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
Ganesh K Boora, Amit A Kulkarni, Rahul Kanwar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
Journal of Adolescent and Young Adult Oncology
|
February 3, 2026
Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment
Karly M Ingram, Janet A Tooze, Sharon M Castellino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2022
A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia
Dawn L Hershman, Aasthaa Bansal, Sean D Sullivan, et al.
JAMA Network Open
|
October 24, 2022
Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial
Scott D Ramsey, Aasthaa Bansal, Sean D Sullivan, et al.
Breast Cancer Research and Treatment
|
November 9, 2013
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])
Harry H Yoon, Fang-Shu Ou, Gamini S Soori, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Pharmacoeconomics
|
August 27, 2014
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer
Steven R Alberts, Tiffany M Yu, Robert J Behrens, et al.
Journal of the Neurological Sciences
|
July 6, 2015
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance)
Ganesh K Boora, Amit A Kulkarni, Rahul Kanwar, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 1, 2010
Phase II evaluation of gefitinib in patients with newly diagnosed Grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074
Joon H Uhm, Karla V Ballman, Wenting Wu, et al.
Journal of Adolescent and Young Adult Oncology
|
February 3, 2026
Work Ability in Young Adult Survivors (WAYS WF-10217): Documenting Labor Force Participation, Occupation, and Educational Attainment Following Cancer Treatment
Karly M Ingram, Janet A Tooze, Sharon M Castellino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 13, 2022
A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia
Dawn L Hershman, Aasthaa Bansal, Sean D Sullivan, et al.
JAMA Network Open
|
October 24, 2022
Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial
Scott D Ramsey, Aasthaa Bansal, Sean D Sullivan, et al.
Breast Cancer Research and Treatment
|
November 9, 2013
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43
Kalliopi P Siziopikou, Stewart J Anderson, Melody A Cobleigh, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])
Harry H Yoon, Fang-Shu Ou, Gamini S Soori, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
The New England Journal of Medicine
|
March 25, 2026
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer
Frank A Sinicrope, Fang-Shu Ou, Dirk Arnold, et al.
Page
of 3